Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 40% decrease from the number of companies cited in the previous quarter.
The citations in the county include:
- An MDR report was not submitted within 30 days of receiving or otherwise becoming aware of information that reasonably suggests that a marketed device has malfunctioned and would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.
- Service reports that represent MDR reportable events were not automatically considered complaints and processed in accordance with the requirements of 21 CFR 820.198.
- The responsibilities and procedures applicable to the quality control unit are not fully followed.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Eagle Labs, Inc. | Drugs | 12/06/2023 | Written procedures not established/followed |
Eagle Labs, Inc. | Drugs | 12/06/2023 | SOPs not followed / documented |
Infinium Medical, Inc. | Devices | 11/08/2023 | Individual Report of Malfunction |
Infinium Medical, Inc. | Devices | 11/08/2023 | Service reports/MDRs/complaints |
Pharmetric Laboratory, LLC | Drugs | 11/06/2023 | Procedures not in writing, fully followed |